Low-dose cyclosporin for multiple colonic ulcers associated with mixed connective tissue disease

Clinical Rheumatology

Volumn 18, Issue 5, 1999, Pages 410-413

  Maeda, N ^a   Abe, S ^a   Yoshizawa, T ^a   Ogawa, K ^a   Sekigawa, Iwao ^a   Iida, N ^a   Eguchi, M ^a   Matsumoto, M ^a   Hashimoto, H ^b   Hirose, S ^a  

^a JUNTENDO UNIVERSITY SHIZUOKA HOSPITAL   (Japan)

^b JUNTENDO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Colonic ulcer; Cyclosporin; Mixed connective tissue disease

Indexed keywords

CYCLOSPORIN;

ADULT; ARTICLE; CASE REPORT; COLON ULCER; DISEASE ASSOCIATION; DOSE RESPONSE; DRUG EFFICACY; DRUG MECHANISM; FEMALE; HUMAN; LYMPHOCYTIC INFILTRATION; MIXED CONNECTIVE TISSUE DISEASE; PERIPHERAL LYMPHOCYTE; PRIORITY JOURNAL; T LYMPHOCYTE ACTIVATION; VASCULITIS;

EID: 0032850879     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100670050128     Document Type: Article

References (15)

1. Marshall JB, Kretschmar JM, Gerhardt DC, et al. Gastrointestinal manifestations of mixed connective tissue disease. Gastroenterology 1990;98:1232-8.
2. + T cells in systemic lupus erythematosus: alterations associated with prednisolone therapy. Scand J Rheumatol 1990;31:139-49.
3. + cells. J Rheumatol 1988;15:946-51.
4. Tokano Y, Morimoto S, Hishikawa T, et al. Subsets of activated T cells in patients with systemic lupus erythematosus: the relation to cell cycle. Scand J Rheumatol 1997;26:37-42.
5. Norman DA, Fleischmann RM. Gastrointestinal systemic sclerosis in serologic mixed connective tissue disease. Arthritis Rheum 1978;21:811-9.
6. Cooke C, Lurie HI. Case report: fatal gastrointestinal hemorrhage in connective tissue disease. Arthritis Rheum 1977;20:1421-7.
7. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 1990;335:1078.
8. Schreiber SL, Crabtree GR. The mechanism of action of cyclosporin A and FK506. Immunol Today 1992;13:136-42.
9. Center DM, Kornfeld H, Cruikshank WW. Interleukin 16 and its function as a CD4 ligand. Immunol Today 1996;17:476-81.
10. Mahrle G, Schultze HJ, Farber L, Weidinger G, Steigleder GK. Low-dose short-term cyclosporine versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol 1995;32:78-88.
11. Tokuda M, Kurata N, Mizoguchi A, et al. Effect of low-dose cyclosporine A on systemic lupus erythematosus disease activity. Arthritis Rheum 1994;37:551-8.
12. Sugiyama M, Ogasawara H, Kaneko H, et al. Effect of extremely low dose cyclosporine treatment on the thrombocytopenia in systemic lupus erythematosus. Lupus 1998;7:53-6.
13. Ogasawara H, Murashima A, Kaneko H, et al. Effect of low dose cyclosporine treatment on interstitial pneumonitis associated with Sjögren's syndrome. Br J Rheumatol 1998;37:348-9.
14. List AF, Spier C, Greer J, et al. Phase I/II trial of cyclosporine as a chemotherapy-resistance modifier in acute leukemia. J Clin Oncol 1993;11:1652-60.
15. Maillefert JF, Maynadie M, Tebib JG, et al. Expression of the multidrug resistance glycoprotein 170 in the peripheral blood lymphocytes of rheumatoid arthritis patients. The percentage of lymphocytes expressing glycoprotein 170 is increased in patients treated with prednisolone. Br J Rheumatol 1996;35:430-5.